What’s somewhat different than CYDY is the share structure and current cash on hand. I see there are 2.11 billion outstanding shares, which is a large amount for a penny stock. I’m looking into the financials now I’m regards to how much cash and debt they have. If cash is low, a raise could come at anytime with this big of a run. Additionally, with 2.11 billion shares outstanding, they could do a reverse split, make an offering for stock to raise funds, and uplist.
(0)
(1)
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links